Drug · DIN 02416166
IPG-PREGABALIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 26, 2016.
- Drug Identification Number (DIN)
- 02416166
- Company (DIN owner)
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pregabalin N02BF02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PREGABALIN | 75 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 26, 2016: NOC 18301Abbreviated New Drug Submission (ANDS) · Administrative - Merger/Buyout Updates to the Product Monograph
- January 24, 2014: NOC 15152Abbreviated New Drug Submission (ANDS)
Other DINs named IPG-PREGABALIN
- DIN 02416131 · Approved
- DIN 02416158 · Approved
- DIN 02416174 · Approved
- DIN 02416182 · Approved
- DIN 02416190 · Approved
- DIN 02416204 · Approved
- DIN 02416212 · Approved